Sir,
Eyelid skin atrophy associated with chronic usage of ophthalmic steroid ointment, and its successful treatment with the Versapulse laser Long-term topical corticosteroids are used with caution in the eye for fear of their potential side-effects such as raised intraocular pressure and cataract formation. Skin atrophy is a well-documented side-effect of the long term use of dermatological preparations of corticosteroids, related to the thickness of the skin to which they are applied, the potency of the steroid and the duration of its use. We describe a patient who sustained dermatological eyelid change following the use of an ophthalmic steroid preparation, and who was then successfully treated by novel means.
Case report
A 55-year-old woman presented to the eye clinic complaining of a 5 year history of recurrent 'bruised eyes', often upon waking. She stated that prominent blood vessels had developed within her lower eyelid skin and that extensive bruising of the lids frequently occurred with minimal, if any, physical contact. There was no history of trauma or atopy. In response to direct questioning, she disclosed that for more than 30 years she had been applying Betnesol (Evans) ophthalmic ointment, obtained on repeat prescription from her general practitioner, onto her eyelids as treatment for blepharitis.
On examination, the lower eyelid skin was atrophic with underlying prominent, dilated blood vessels and visible orbital fat. There was a mild degree of anterior blepharitis but no other signs of skin or ocular disease (Fig. 1) . A diagnosis of corticosteroid-related skin atrophy was made. In addition to cessation of ointment 
